Evidence map›Paper›PMID 28494067›Full record

Trial reportJAMA ophthalmology2017

Association of Dietary Vitamin K1 Intake With the Incidence of Cataract Surgery in an Adult Mediterranean Population: A Secondary Analysis of a Randomized Clinical Trial.

María L Camacho-Barcia, Mònica Bulló, Jesús F Garcia-Gavilán, Miguel Ruiz-Canela, Dolores Corella, Ramón Estruch, Montserrat Fitó, Alfredo García-Layana, Fernando Arós, Miquel Fiol and 7 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

María L Camacho-BarciaHuman Nutrition Unit, Biochemistry and Biotechnology Department, University Hospital of Sant Joan de Reus, Reus, Spain.
Mònica BullóHuman Nutrition Unit, Biochemistry and Biotechnology Department, University Hospital of Sant Joan de Reus, Reus, Spain2Centro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
Jesús F Garcia-GavilánHuman Nutrition Unit, Biochemistry and Biotechnology Department, University Hospital of Sant Joan de Reus, Reus, Spain.
Miguel Ruiz-CanelaCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain3Department of Preventive Medicine and Public Health, Medical School, University of Navarra, Pamplona, Spain.
Dolores CorellaCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain4Department of Preventive Medicine, University of Valencia, Valencia, Spain.
Ramón EstruchCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain5Department of Internal Medicine, August Pi i Sunyer Institute of Biomedical Research, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Montserrat FitóCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain6Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Medical Research Institute, Barcelona Biomedical Research Park, Barcelona, Spain.
Alfredo García-LayanaCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain7Department of Ophthalmology, University of Navarra, Pamplona, Spain.
Fernando ArósCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain8Department of Cardiology, Hospital Txangorritxu, Vitoria, Spain.
Miquel FiolCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain9Department of Cardiology, Hospital Universitario Son Dureta, Palma de Mallorca, Spain.
José LapetraCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain10San Pablo Health Center, Sevilla, Spain.
Lluis Serra-MajemCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain11Research Institut of Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
Xavier PintóCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain12Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Barcelona, Spain.
Ana García-ArellanoCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain3Department of Preventive Medicine and Public Health, Medical School, University of Navarra, Pamplona, Spain13Emergency Department, Complejo Hospitalario de Navarra, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain.
Ernest VinyolesCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain6Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Medical Research Institute, Barcelona Biomedical Research Park, Barcelona, Spain.
José Vicente SorliCentro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain4Department of Preventive Medicine, University of Valencia, Valencia, Spain.
Jordi Salas-SalvadóHuman Nutrition Unit, Biochemistry and Biotechnology Department, University Hospital of Sant Joan de Reus, Reus, Spain2Centro de Investigación Biomédica en Red Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESInstituto de Salud Carlos III · ESHospital Universitari Sant Joan de Reus · ESCentro de Investigación Biomédica en Red · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Cataract, one of the most frequent causes of blindness in developed countries, is strongly associated with aging. The exact mechanisms underlying cataract formation are still unclear, but growing evidence suggests a potential role of inflammatory and oxidative processes. Therefore, antioxidant and anti-inflammatory factors of the diet, such as vitamin K1, could play a protective role. Objective: To examine the association between dietary vitamin K1 intake and the risk of incident cataracts in an elderly Mediterranean population. Design, Setting, and Participants: A prospective analysis was conducted in 5860 participants from the Prevención con Dieta Mediterránea Study, a randomized clinical trial executed between 2003 and 2011. Participants were community-dwelling men (44.2%) and women (55.8%), and the mean (SD) age was 66.3 (6.1) years. Main Outcomes and Measures: Dietary vitamin K1 intake was evaluated using a validated food frequency questionnaire. The time to the cataract event was calculated as the time between recruitment and the date of the occurrence to cataract surgery, the time to the last visit of the follow-up, date of death, or the end of the study. Hazard ratios and 95% CIs for cataract incidence were estimated with a multivariable Cox proportional hazards model. Results: Participants were community-dwelling men (44.2%; n = 868) and women (55.8%; n = 1086), and the mean (SD) age was 66.3 (6.1) years. After a median of 5.6 years follow-up, we documented a total of 768 new cataracts. Participants in the highest tertile of dietary vitamin K1 intake had a lower risk of cataracts than those in the lowest tertile (hazard ratio, 0.71; 95% CI, 0.58-0.88; P = .002), after adjusting for potential confounders. Conclusions and Relevance: High intake of dietary vitamin K1 was associated with a reduced risk of cataracts in an elderly Mediterranean population even after adjusting by other potential confounders. Trial Registration: isrctn.org: ISRCTN35739639.

Indexed as

Dietary SupplementsRisk AssessmentAgedCardiovascular DiseasesCataractCataract ExtractionFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRisk FactorsSpainVitamin K 1VitaminsVitamin K 1Vitamins

Identifiers

PMID28494067
PMCPMC5847084
OpenAlexW2613216232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.